Companion Diagnostics Market Report 2026
Download Free Sample Buy Now
Companion Diagnostics Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Companion Diagnostics Market Report 2026

Global Outlook – By Product And Service (Assays, Kits And Reagents, Software And Services), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma), By End-User (Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Companion Diagnostics Market Overview

• Companion Diagnostics market size has reached to $8.69 billion in 2025

• Expected to grow to $22.7 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%

• Growth Driver: The Surge In Targeted Therapies Fueling The Expansion Of Companion Diagnostics

• Market Trend: Innovative Companion Diagnostics Transforming Precision Medicine In Non-Small Cell Lung Cancer

• North America was the largest region in 2025.

What Is Covered Under Companion Diagnostics Market?

Companion diagnostics is an in vitro diagnostic medical test used to check the safety and effectivity of a corresponding drug or biological product. The test aids a medical expert to match a patient to a specific drug or therapy.

The main products and services of companion diagnostics are assays, kits and reagents and software and services. Assays, kits and reagents are used in various life science, environmental, and research labs. An assay is a procedure for examining a substance to ascertain its composition or quality. Kits are a set or collection of equipment, materials, or instruction for a particular use. A reagent is a chemical used in laboratory testing to make, measure, or detect other compounds. Polymerase chain reaction, next-generation sequencing, in situ hybridization and immunohistochemistry are the technologies used in companion diagnostics. The companion diagnostics are used for identifying lung, breast, colorectal, leukemia and melanoma cancer diseases. Pharmaceutical and biopharmaceutical companies, reference laboratories and contract research organizations use companion diagnostics.

Companion Diagnostics market report bar graph

What Is The Companion Diagnostics Market Size and Share 2026?

The companion diagnostics market size has grown exponentially in recent years. It will grow from $8.69 billion in 2025 to $10.54 billion in 2026 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growth in targeted cancer therapies, expansion of oncology clinical trials, increased collaboration between pharma and diagnostics firms, rising cancer incidence rates, regulatory approvals for companion tests.

What Is The Companion Diagnostics Market Growth Forecast?

The companion diagnostics market size is expected to see exponential growth in the next few years. It will grow to $22.7 billion in 2030 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to increasing demand for personalized treatment selection, rising investments in precision medicine, expansion of immuno-oncology pipelines, growing adoption of ai-driven diagnostic interpretation, increasing regulatory emphasis on diagnostic-drug co-development. Major trends in the forecast period include increasing adoption of precision oncology diagnostics, rising integration of companion diagnostics in drug development, growing use of ngs-based diagnostic platforms, expansion of biomarker-driven therapies, enhanced focus on personalized medicine.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Companion Diagnostics Market Segmentation

1) By Product And Service: Assays, Kits And Reagents, Software And Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry

3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma

4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations

Subsegments:

1) By Assays: Polymerase Chain Reaction (PCR) Assays, Immunohistochemistry (IHC) Assays, Next-Generation Sequencing (NGS) Assays, In Situ Hybridization (ISH) Assays

2) By Kits And Reagents: Diagnostic Kits, Detection Reagents, Control Reagents

3) By Software And Services: Data Analysis Software, Interpretation Software, Custom Development Services, Consulting and Support Services

What Is The Driver Of The Companion Diagnostics Market?

The increasing number of targeted therapies is expected to propel the growth of the companion diagnostics market. Targeted therapy is a pharmacological therapy that targets particular characteristics of cancer cells to inhibit the growth and spread of the disease. The medications circulate throughout the body but have a more targeted effect than chemotherapy and frequently have fewer adverse effects. Biological marker-based companion diagnostic testing for targeted cancer therapy is becoming an essential part of personalized cancer care. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. Therefore, the surge in targeted therapies drives growth in the companion diagnostics industry.

Key Players In The Global Companion Diagnostics Market

Major companies operating in the companion diagnostics market are F Hoffmann-La Roche Ltd., Agilent Technologies Inc., Qiagen NV, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Amoy Diagnostics Co. Ltd., Danaher Corporation, Guardant Health Inc., Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Caris Life Sciences, Cepheid Inc., Diaceutics plc, Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Precision Therapeutics Inc., Prometheus Laboratories Inc., Sysmex Corporation, Ventana Medical Systems

Global Companion Diagnostics Market Trends and Insights

Major companies operating in the companion diagnostics market are collaborating to develop innovative treatment solutions to enhance personalized medicine, improve patient outcomes, and optimize the effectiveness of targeted therapies. Collaboration of the companies will accelerate the development and commercialization of companion diagnostics (CDx) for hematology and oncology treatments. For instance, in January 2024, Agilent Technologies, Inc., a US-based company that provides instruments, software, services, and consumables for laboratories, announced an agreement with Incyte, a US-based pharmaceutical company. This will bring together Agilent’s expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte’s hematology and oncology portfolio. This collaboration allows Agilent to expand its CDx portfolio with new biomarkers, while Incyte benefits from Agilent's expertise in assay development, regulatory approvals, and commercialization to support clinical trials and CDx registration in the U.S. and Europe.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Companion Diagnostics Market?

In September 2023, Exact Sciences, a US-based provider of molecular diagnostics and precision oncology tests, acquired Resolution Bioscience for an undisclosed amount. Through this acquisition, Exact Sciences aims to enhance its companion diagnostic capabilities by integrating Resolution Bioscience’s ctDx FIRST liquid biopsy platform and expanding its portfolio of precision oncology assays. Resolution Bioscience is a US-based company that provides next-generation sequencing (NGS)-based liquid biopsy tests to detect actionable tumor mutations and guide targeted therapy.

Regional Outlook

North America was the largest region in the companion diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Companion Diagnostics Market?

The companion diagnostics market includes revenues earned by theranostics and monitoring tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Companion Diagnostics Market Report 2026?

The companion diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the companion diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Companion Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $10.54 billion
Revenue Forecast In 2035 $22.7 billion
Growth Rate CAGR of 21.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product And Service, Technology, Indication, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F Hoffmann-La Roche Ltd., Agilent Technologies Inc., Qiagen NV, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Amoy Diagnostics Co. Ltd., Danaher Corporation, Guardant Health Inc., Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Caris Life Sciences, Cepheid Inc., Diaceutics plc, Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Precision Therapeutics Inc., Prometheus Laboratories Inc., Sysmex Corporation, Ventana Medical Systems
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Companion Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Companion Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Companion Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Companion Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Adoption Of Precision Oncology Diagnostics

4.2.2 Rising Integration Of Companion Diagnostics In Drug Development

4.2.3 Growing Use Of Ngs-Based Diagnostic Platforms

4.2.4 Expansion Of Biomarker-Driven Therapies

4.2.5 Enhanced Focus On Personalized Medicine

5. Companion Diagnostics Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biopharmaceutical Companies

5.3 Reference Laboratories

5.4 Contract Research Organizations

5.5 Academic Medical Centers

6. Companion Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Companion Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Companion Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Companion Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Companion Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Companion Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Companion Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Companion Diagnostics Market Segmentation

9.1. Global Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Assays, Kits And Reagents, Software And Services

9.2. Global Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry

9.3. Global Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma

9.4. Global Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations

9.5. Global Companion Diagnostics Market, Sub-Segmentation Of Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR) Assays, Immunohistochemistry (IHC) Assays, Next-Generation Sequencing (NGS) Assays, In Situ Hybridization (ISH) Assays

9.6. Global Companion Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Kits, Detection Reagents, Control Reagents

9.7. Global Companion Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Data Analysis Software, Interpretation Software, Custom Development Services, Consulting and Support Services

10. Companion Diagnostics Market Regional And Country Analysis

10.1. Global Companion Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Companion Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Companion Diagnostics Market

11.1. Asia-Pacific Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Companion Diagnostics Market

12.1. China Companion Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Companion Diagnostics Market

13.1. India Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Companion Diagnostics Market

14.1. Japan Companion Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Companion Diagnostics Market

15.1. Australia Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Companion Diagnostics Market

16.1. Indonesia Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Companion Diagnostics Market

17.1. South Korea Companion Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Companion Diagnostics Market

18.1. Taiwan Companion Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Companion Diagnostics Market

19.1. South East Asia Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Companion Diagnostics Market

20.1. Western Europe Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Companion Diagnostics Market

21.1. UK Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Companion Diagnostics Market

22.1. Germany Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Companion Diagnostics Market

23.1. France Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Companion Diagnostics Market

24.1. Italy Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Companion Diagnostics Market

25.1. Spain Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Companion Diagnostics Market

26.1. Eastern Europe Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Companion Diagnostics Market

27.1. Russia Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Companion Diagnostics Market

28.1. North America Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Companion Diagnostics Market

29.1. USA Companion Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Companion Diagnostics Market

30.1. Canada Companion Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Companion Diagnostics Market

31.1. South America Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Companion Diagnostics Market

32.1. Brazil Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Companion Diagnostics Market

33.1. Middle East Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Companion Diagnostics Market

34.1. Africa Companion Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Companion Diagnostics Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Companion Diagnostics Market Regulatory and Investment Landscape

36. Companion Diagnostics Market Competitive Landscape And Company Profiles

36.1. Companion Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Companion Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Companion Diagnostics Market Company Profiles

36.3.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Companion Diagnostics Market Other Major And Innovative Companies

Amoy Diagnostics Co. Ltd., Danaher Corporation, Guardant Health Inc., Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Caris Life Sciences, Cepheid Inc., Diaceutics plc, Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc.

38. Global Companion Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Companion Diagnostics Market

40. Companion Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Companion Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Companion Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Companion Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Companion Diagnostics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Companion Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Companion Diagnostics Market, Supply Chain Analysis
  • Table 4: Global Companion Diagnostics Market, Major Raw Material Providers
  • Table 5: Global Companion Diagnostics Market, Major Resource Providers
  • Table 6: Global Companion Diagnostics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Companion Diagnostics Market, Major Distributors And Channel Partners
  • Table 8: Global Companion Diagnostics Market, Key Technologies & Future Trends
  • Table 9: Global Companion Diagnostics Market, Major Trends
  • Table 10: Global Companion Diagnostics Market, Major End Users
  • Table 11: Global Companion Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Companion Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Companion Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Companion Diagnostics Market - TAM, US$ Billion, 2025
  • Table 15: Global Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Companion Diagnostics Market, Sub-Segmentation Of Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Companion Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Companion Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Companion Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Companion Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Companion Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Companion Diagnostics Market - Company Scoring Matrix
  • Table 98: F Hoffmann-La Roche Ltd. Financial Performance
  • Table 99: Agilent Technologies Inc. Financial Performance
  • Table 100: Qiagen NV Financial Performance
  • Table 101: Thermo Fisher Scientific Inc. Financial Performance
  • Table 102: Abbott Laboratories Inc. Financial Performance
  • Table 103: Global Companion Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Companion Diagnostics Market, Competitive Dashboard
  • Table 105: Global Companion Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Product And Service, 2025 – 2030
  • Table 107: Global, Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 108: Global, Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Companion Diagnostics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Companion Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Companion Diagnostics Market, Supply Chain Analysis
  • Figure 4: Global Companion Diagnostics Market, Major Raw Material Providers
  • Figure 5: Global Companion Diagnostics Market, Major Resource Providers
  • Figure 6: Global Companion Diagnostics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Companion Diagnostics Market, Major Distributors And Channel Partners
  • Figure 8: Global Companion Diagnostics Market, Key Technologies & Future Trends
  • Figure 9: Global Companion Diagnostics Market, Major Trends
  • Figure 10: Global Companion Diagnostics Market, Major End Users
  • Figure 11: Global Companion Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Companion Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Companion Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Companion Diagnostics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Companion Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Companion Diagnostics Market, Sub-Segmentation Of Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Companion Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Companion Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Companion Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Companion Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Companion Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Companion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Companion Diagnostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Companion Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Companion Diagnostics Market - Company Scoring Matrix
  • Figure 98: F Hoffmann-La Roche Ltd. Financial Performance
  • Figure 99: Agilent Technologies Inc. Financial Performance
  • Figure 100: Qiagen NV Financial Performance
  • Figure 101: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 102: Abbott Laboratories Inc. Financial Performance
  • Figure 103: Global Companion Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Companion Diagnostics Market, Competitive Dashboard
  • Figure 105: Global Companion Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Product And Service, 2025 – 2030
  • Figure 107: Global, Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 108: Global, Companion Diagnostics Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Electroencephalography (EEG) And Electromyography (EMG) Equipment Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Electroencephalography (EEG) And Electromyography (EMG) Equipment Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Electroencephalography Devices Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Electroencephalography Devices Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Electromyography EMG Electrode Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Electromyography EMG Electrode Market Trends: Regional Breakdowns and Strategic Insights

Electrophysiology Catheters Outlook 2034: Key Drivers, Trends, and Market Frontiers

Read More About Electrophysiology Catheters Outlook 2034: Key Drivers, Trends, and Market Frontiers

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Read More About The global medical gloves market report offers strategic insights and market intelligence through 2025.

Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Read More About Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Read More About Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Read More About Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Sulfur Market Report 2026 - Global Outlook – By Type (Fertilizers, Chemical Processing, Sulfur-Metal Manufacturing, Petroleum Refining, Other Types), By Mining Type (Underground Mining, Surface Mining), By End-Use (Agric...

Allogeneic T Cell Therapies Market Report 2026 - Global Outlook – By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, C...

Clinical Trial Site Management Organizations Market Report 2026 - Global Outlook – By Services (Site Management, Project Management, Regulatory, Onsite Monitoring), By Phase (Phase I, Phase II, Phase III, Phase IV), By T...

Note Sorter Market Report 2026 - Global Outlook – By Sorter Type (Small-Sized Note Sorter, Medium-Sized Note Sorter, Large-Sized Note Sorter), By Enterprise Size (Large Enterprises, Small And Medium Enterprises ), By End...

Organic Pigments Market Report 2026 - Global Outlook – By Type (Azo Pigments, Pthalocyanine Pigments, High Performance Pigments (HPPs), Alizarin, Arylide, Other Types), By Source (Synthetic, Natural), By End-Use (Textile...

Cryogenic Tanks Market Report 2026 - Global Outlook – By Cryogenic Liquid (Liquefied Natural Gas (LNG), Liquid Nitrogen, Liquid Oxygen, Liquid Hydrogen, Other Cryogenic Liquids), By Raw Material (Steel, Nickel Alloy, Alu...

Merkel Cell Carcinoma Treatment Market Report 2026 - Global Outlook – By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), By Therapy (Surgical Excision, Micrographic Surgery, Radiation, Chemotherapy,...

Epileptic Seizures Treatment Market Report 2026 - Global Outlook – By Type (Treatment Practices, Emerging Drugs, Individual Therapies), By Seizure Type (Partial Seizures, Generalized Seizures, Unclassified Seizures), By ...

Frequently Asked Questions

The Companion Diagnostics Market Report 2026 market was valued at $8.69 billion in 2025, increased to $10.54 billion in 2026, and is projected to reach $22.7 billion by 2030. request a sample here

The expected CAGR for the Companion Diagnostics Market Report 2026 market during the forecast period 2025–2030 is 21.1%. request a sample here

Major growth driver of the market includes: The Surge In Targeted Therapies Fueling The Expansion Of Companion Diagnostics in the Companion Diagnostics Market Report 2026 market. For further insights on this market, request a sample here

The companion diagnostics market covered in this report is segmented –
1) By Product And Service: Assays, Kits And Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry
3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations Subsegments:
1) By Assays: Polymerase Chain Reaction (PCR) Assays, Immunohistochemistry (IHC) Assays, Next-Generation Sequencing (NGS) Assays, In Situ Hybridization (ISH) Assays
2) By Kits And Reagents: Diagnostic Kits, Detection Reagents, Control Reagents
3) By Software And Services: Data Analysis Software, Interpretation Software, Custom Development Services, Consulting and Support Services request a sample here

Major trend in this market includes: Innovative Companion Diagnostics Transforming Precision Medicine In Non-Small Cell Lung Cancer For further insights on this market, request a sample here.

Major companies operating in the Companion Diagnostics Market Report 2026 market are Major companies operating in the companion diagnostics market are F Hoffmann-La Roche Ltd., Agilent Technologies Inc., Qiagen NV, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Amoy Diagnostics Co. Ltd., Danaher Corporation, Guardant Health Inc., Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Caris Life Sciences, Cepheid Inc., Diaceutics plc, Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Precision Therapeutics Inc., Prometheus Laboratories Inc., Sysmex Corporation, Ventana Medical Systems request a sample here.

North America was the largest region in the companion diagnostics market in 2025. The regions covered in the companion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us